Switch theme
Sign up to access all valuation multiples
Beijing Airdoc Technology Co Ltd provides AI-empowered retina-based early detection, diagnosis, and health risk assessment solutions in China. Leveraging retinal imaging, multimodal data analyses, and AI deep learning algorithms, the company's solution differs from traditional chronic disease early detection and diagnosis, enabling non-invasive, accurate, fast, effective, and scalable detection and diagnosis of chronic diseases in both medical institutions and consumer healthcare providers. The Company derives revenue principally from the provision of AI-based software solutions, sales of hardware devices, and other services.
2015
339
LTM Revenue $24.8M
LTM EBITDA -$32.8M
$43.5M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Airdoc has a last 12-month revenue of $24.8M and a last 12-month EBITDA of -$32.8M.
In the most recent fiscal year, Airdoc achieved revenue of $26.2M and an EBITDA of -$14.6M.
Airdoc expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Airdoc valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $14.6M | $26.2M | XXX | XXX | XXX |
| Gross Profit | $9.0M | $7.2M | XXX | XXX | XXX |
| Gross Margin | 62% | 27% | XXX | XXX | XXX |
| EBITDA | -$20.5M | -$14.6M | XXX | XXX | XXX |
| EBITDA Margin | -140% | -56% | XXX | XXX | XXX |
| Net Profit | -$18.3M | -$23.1M | XXX | XXX | XXX |
| Net Margin | -125% | -88% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Airdoc's stock price is HKD 11 (or $1).
Airdoc has current market cap of HKD 1.1B (or $145M), and EV of HKD 338M (or $43.5M).
See Airdoc trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $43.5M | $145M | XXX | XXX | XXX | XXX | $-0.29 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Airdoc has market cap of $145M and EV of $43.5M.
Airdoc's trades at 1.9x LTM EV/Revenue multiple, and -1.4x LTM EBITDA.
Analysts estimate Airdoc's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Airdoc and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $43.5M | XXX | XXX | XXX |
| EV/Revenue | 1.7x | XXX | XXX | XXX |
| EV/EBITDA | -3.0x | XXX | XXX | XXX |
| P/E | -8.5x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | 42.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpAirdoc's NTM/LTM revenue growth is 26%
Airdoc's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $0.1M for the same period.
Over next 12 months, Airdoc's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Airdoc's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Airdoc and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 79% | XXX | XXX | XXX | XXX |
| EBITDA Margin | -56% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -29% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | -29% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.1M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 49% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 49% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 55% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 152% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Australian Clinical Labs | XXX | XXX | XXX | XXX | XXX | XXX |
| Clarity Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| CurveBeam AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Cyclopharm | XXX | XXX | XXX | XXX | XXX | XXX |
| Healius | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Airdoc acquired XXX companies to date.
Last acquisition by Airdoc was XXXXXXXX, XXXXX XXXXX XXXXXX . Airdoc acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Airdoc founded? | Airdoc was founded in 2015. |
| Where is Airdoc headquartered? | Airdoc is headquartered in Hong Kong. |
| How many employees does Airdoc have? | As of today, Airdoc has 339 employees. |
| Is Airdoc publicy listed? | Yes, Airdoc is a public company listed on HKG. |
| What is the stock symbol of Airdoc? | Airdoc trades under 02251 ticker. |
| When did Airdoc go public? | Airdoc went public in 2021. |
| Who are competitors of Airdoc? | Similar companies to Airdoc include e.g. Australian Clinical Labs, Clarity Pharmaceuticals, CurveBeam AI, Cyclopharm. |
| What is the current market cap of Airdoc? | Airdoc's current market cap is $145M |
| What is the current revenue of Airdoc? | Airdoc's last 12-month revenue is $24.8M. |
| What is the current EBITDA of Airdoc? | Airdoc's last 12-month EBITDA is -$32.8M. |
| What is the current EV/Revenue multiple of Airdoc? | Current revenue multiple of Airdoc is 1.9x. |
| What is the current EV/EBITDA multiple of Airdoc? | Current EBITDA multiple of Airdoc is -1.4x. |
| What is the current revenue growth of Airdoc? | Airdoc revenue growth between 2023 and 2024 was 79%. |
| Is Airdoc profitable? | Yes, Airdoc is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
